Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Walid Shaib, MD
Emory University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic-Arizona
Scottsdale, Arizona, United States
- Emory University: Winship Cancer Institute
Atlanta, Georgia, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Community Healthcare System
Munster, Indiana, United States
- University of Louisville, James Graham Brown Cancer Center
Louisville, Kentucky, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States
- Thomas Jefferson University Kimmel Cancer Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2016
- Primary completion
- 5 Aug 2021
- Completion
- 27 Jan 2022
- Last update posted
- 1 Jan 2025
- Registered enrollment
- 84
- Registry id
- NCT02581215
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.